|
Proteomics Australia offers world class proteomics infrastructure, expertise and advanced protein discovery services for the life science, agri-food and human health sectors. The Proteomics Australia consortium includes seven partners that offer a broad range of proteomic services together with mass spectrometry and monoclonal antibody production. Services and partners cover the following:
High throughput proteomics and protein biochemistry
State-of-the-art equipment, including mass spectrometry and high pressure liquid chromatography (HPLC) together with specialist expertise, ensure first class services are offered in:
- protein characterisation, quantification and identification
- protein sequencing
- protein separation
- post translational modifications
- biomarker discovery
- screening and multiplexing assays
- protein arrays
- amino acid analysis.
Partners providing comprehensive proteomics services
Australian Proteomics Analysis Facility, Macquarie University
Monash Biomedical Proteomics Facility
Adelaide Proteomics Centre
Mass spectrometry specialists
Bioanalytical Mass Spectrometry Facility (BMSF)
Drug discovery and screening specialists
TGR BioSciences Pty Ltd
Post translational modification and specialist expertise in infectious disease
Queensland Institute of Medical Research (QIMR)
Monoclonal antibody production
The Monash Antibody Technology Facility (MATF) was commissioned with the latest robotics technology in 2009 and is one of the highest throughput antibody development facilities in the world. It also offers powerful new assays for discovery research and drug development.
Proteomics Australia PDF Handout |
